Board of Directors
Damien McDonaldChief Executive Officer and Director
Damien McDonald is the Chief Executive Officer of LivaNova.
Previously, Mr. McDonald served as Chief Operating Officer of LivaNova. Prior to that, he was Group Executive and Corporate Vice President at Danaher Corporation where he led a $1.5-billion group of dental consumables companies. Earlier in his tenure, he was Group President of Kerr where he and his team focused on building a strong research and development pipeline while improving operational performance utilizing the Danaher Business System. Additionally, Mr. McDonald previously led Zimmer’s spine division where he demonstrated his leadership skills, attracting a strong executive team that created a growth trajectory for the business unit. Earlier in his career, he worked with J&J’s Medical Device Franchises, including Ethicon, where he led marketing of the $2.5-billion medical device unit.
Mr. McDonald earned an MBA at the Institute for Management Development (IMD) in Lausanne, Switzerland, along with a Master of Science in International Economics from the University of Wales, U.K. He also holds a Bachelor of Economics degree and Bachelor of Pharmacy degree, both from the University of Queensland, Australia.
Mr. McDonald is a non-executive director of the regenerative medicine company Avita Medical (ASX:AVH).
Mr. Kozy’s particular qualifications for service on LivaNova’s Board include his related board service, extensive management experience in the medical technology industry and broad experience in global strategy, manufacturing, M&A, ERP systems and technology product development.